Crescendo Biologics to present at BIO International and ICCS in San Diego, US
Crescendo Biologics nominated for Mediscience Emerging Star Award
Crescendo Biologics Appoints Philip Bland-Ward as Chief Scientific Officer
Crescendo Biologics’ CEO, Peter Pack to present and participate in panel at Biotech and Money 2017
Crescendo Biologics partners with software-provider, Genedata, on next-generation immuno-oncology and ADC programs.
Crescendo Biologics Appoints Theodora Harold as Chief Financial Officer
Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m
Crescendo strengthens IP portfolio with U.S. patent to transgenic mouse platform for generating Humabody® therapeutics.
Key Oncology Data on Humabody™ Drug Conjugates.
Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property.